Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Generic Drug 180-Day Exclusivity Reform Proposal Is Cost-Neutral, CBO Says

Sep 01 2003

• By The Pink Sheet

Related Content

Generic Drug 180-Day Exclusivity Provisions: Hatch Seeks CBO Score

Aug 04 2003

FDA Generic Rx Reforms Contribute To Medicare Budget Squeeze

Jul 28 2003

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window